A simple blood test—plasma ctDNA—cracked the case of mysterious choroidal metastases, revealing lung cancer and guiding swift treatment. Could this be the future of ocular oncology?

A new study in the American Journal of Ophthalmology pits OCT B-scans against en face imaging to spot early macular atrophy in AMD. The verdict? En face imaging catches what B-scans miss, offering a faster, sharper way to track progression. Dive into the details of this retina research breakthrough!

A recent study suggested a link between glucagon-like peptide 1 (GLP-1) receptor agonists and a slight decrease in intraocular pressure (IOP). However, a new analysis points out potential oversights in the research methodology that may affect the reliability of these findings. Key concerns include the absence of propensity score matching, inadequate consideration of metformin co-usage, and failure to account for known glaucoma risk factors like corticosteroid use. These factors could lead to inaccurate conclusions about the true impact of GLP-1 receptor agonists on IOP.

In this 12-month, multicenter randomized controlled trial, children with high myopia received either repeated low-level red-light (RLRL) therapy with single vision spectacles or single vision spectacles alone. The RLRL group demonstrated significant axial length shortening, a reduction in myopic progression, and increases in choroidal and retinal thickness, indicating that RLRL therapy is a safe and effective method for inhibiting myopia progression in children with high myopia.

This study examines factors influencing visual loss in geographic atrophy (GA) related to age-related macular degeneration. Researchers analyzed clinical trials and observational studies to explore correlations between baseline visual acuity, lesion size, growth rate, foveal involvement, and focality with changes in visual acuity over two years. Key findings reveal faster GA lesion growth correlates with greater vision loss, particularly in eyes with subfoveal or unifocal lesions. Baseline measures, like visual acuity and lesion size, do not predict vision changes. Foveal involvement significantly accelerates vision loss. The study emphasizes identifying high-risk patients and highlights the need for interventions to slow GA progression.

This 5-year study used ultra-widefield imaging to track peripheral retinal changes in 265 eyes of 137 participants from the OPERA ancillary study of AREDS2. Researchers found that while AMD severity increased in the central retina, peripheral AMD features remained common and relatively stable. Interestingly, non-AMD peripheral changes like cobblestone degeneration became more frequent. Notably, the presence of significant peripheral findings did not appear to increase the risk of progression to advanced AMD. The study suggests AMD has pan-retinal involvement, but peripheral findings weren't predictive of advanced disease progression in this cohort.

This prospective study explored virtual reality-based infrared pupillometry (VIP) as a tool for detecting long COVID. Researchers recorded pupillary light responses in 185 participants using a VR headset and analyzed nine waveform features. They found that constriction time after the brightest light stimulus was significantly linked to long COVID. Machine learning models, particularly an LSTM model analyzing the full pupillary response, achieved high accuracy (up to 93.75%) in distinguishing long COVID from both post-COVID individuals and healthy controls. The study concludes that VIP shows potential as a non-invasive, affordable, and portable method for the objective detection and monitoring of long COVID, representing the first use of VR-based pupillometry for this purpose.